CellWell record HH-432972
Real world incidence, predictors and outcomes of endocrine immune-related adverse events following immune checkpoint inhibitors
Shuwen Tan; Yuhan Wang; Yunjia Cai; Hongzhou Guo; Ying Gao
2026
In plain language
Among 269 cancer patients starting immune checkpoint inhibitors, 31.6% developed endocrine immune-related side effects, and female sex and prior chemotherapy were linked to thyroid injury.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-432972
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.